C22 Glucosylceramide (d18:1/22:0)

DESCRIPTION

An endogenous glucosylceramide; PLA2 type XIIA knockdown increases expression in rat brain; increased in the brain, but not the liver or spinal cord, of mice fed a methionine-restricted diet; plasma levels increase during exercise and return to basal levels during recovery in human athletes; product contains C22 glucosylceramide isolated from bovine buttermilk

DETAILS

Inchi: InChI=1S/C46H89NO8/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-24-26-28-30-32-34-36-42(50)47-39(38-54-46-45(53)44(52)43(51)41(37-48)55-46)40(49)35-33-31-29-27-25-23-16-14-12-10-8-6-4-2/h33,35,39-41,43-46,48-49,51-53H,3-32,34,36-38H2,1-2H3,(H,47,50)/b35-33+/t39-,40+,41+,43+,44-,45+,46+/m0/s1
Purity: ≥98%
Raptas: Product Type|Biochemicals|Lipids|Sphingolipids||Research Area|Lipid Biochemistry|Sphingolipids||Research Area|Neuroscience
Smiles: O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](OC[C@@H]([C@H](O)/C=C/CCCCCCCCCCCCC)NC(CCCCCCCCCCCCCCCCCCCCC)=O)[C@@H]1O
Inchikey: YIGARKIIFOHVPF-CNUVFPMCSA-N
Cas Number: 119242-44-3
Formulation: A solid
Storage Temp: -20
Shipping Temp: -20
Formula Markup: C46H89NO8
Formula Weight: 784.2
Shelf Life Days: 1460